ProPhase Labs, Inc.
PRPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14,445 | $38,888 | $76,373 | $54,467 |
| - Cash | $678 | $1,609 | $9,109 | $8,408 |
| + Debt | $24,573 | $21,380 | $6,960 | $14,901 |
| Enterprise Value | $38,340 | $58,659 | $74,224 | $60,960 |
| Revenue | $6,770 | $44,384 | $122,647 | $79,042 |
| % Growth | -84.7% | -63.8% | 55.2% | – |
| Gross Profit | -$150 | $16,239 | $70,654 | $32,814 |
| % Margin | -2.2% | 36.6% | 57.6% | 41.5% |
| EBITDA | -$32,336 | -$14,827 | $28,733 | $11,388 |
| % Margin | -477.6% | -33.4% | 23.4% | 14.4% |
| Net Income | -$53,364 | -$16,782 | $18,463 | $6,273 |
| % Margin | -788.2% | -37.8% | 15.1% | 7.9% |
| EPS Diluted | -2.61 | -0.98 | 1.02 | 0.4 |
| % Growth | -166.3% | -196.1% | 155% | – |
| Operating Cash Flow | -$17,538 | -$11,348 | $28,551 | -$13,619 |
| Capital Expenditures | -$906 | -$3,155 | -$3,919 | -$4,231 |
| Free Cash Flow | -$18,444 | -$14,503 | $24,632 | -$17,850 |